Bohra Industries (BOHRAIND)

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• Trades at a 50% discount to book value (P/B 0.50), offering a margin of safety if stated assets are credible.
• Debt/equity is just 0.02, so the balance sheet carries almost no leverage or solvency pressure.
• Book value per share of ₹35.37 is well above the current market price of ₹17.85.
• The 52-week range of ₹12.31–₹33.82 suggests the stock has already corrected sharply from its highs, lowering speculative expectations.

Concerns

• Latest quarterly sales are ₹0 Cr with a net loss of ₹1 Cr, meaning no active revenue generation.
• Piotroski F-Score of 2/9 points to weak fundamental health and poor earnings quality.
• Promoter holding is only 9.81%, raising governance and alignment risks for minority shareholders.
• ROCE is -7.01% and profit growth is -39.53%, indicating ongoing destruction of shareholder capital.

AI Analysis

At first glance, Bohra Industries looks like a classic Graham net-net. The stock trades at ₹17.85 against a book value of ₹35.37, a P/B of 0.50. That discount is large enough to make any value investor pause and look closer. But the deeper I dig, the less comfortable I become. This is a fertilizer company with latest quarterly sales of ₹0 Cr and a net loss of ₹1 Cr. Sales growth is 0.00%, profit growth is -39.53%, and return on capital employed is -7.01%. A P/E of 0.00 and an ROE that is not available merely reinforce what the operating numbers already show: there are no real earnings here. In other words, the operations are not producing any revenue and are destroying value. A business that earns no return on its assets is not a wonderful business, no matter how cheap the shares look. The balance sheet has some strength: debt/equity is only 0.02, so there is no heavy leverage forcing a distress sale. But low debt does not make a broken operation good. The Piotroski score of 2 out of 9 is a serious warning, meaning weak profitability, poor asset efficiency, and questionable fundamental health. Promoter holding is just 9.81%. That is far too low for my comfort; I want management's wealth tightly linked to mine. Equity is not earning its keep. Could this be an asset play? Perhaps. If the book value is real and the assets can be sold or deployed, the market is offering roughly 50 paise for every rupee of net worth. But I cannot assume that without evidence. I need a clear plan to unlock value, a restart of operations, or a catalyst. Until then, this is a cheap balance sheet with no earning power, and I will wait on the sidelines.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer